Fatty liver: Difference between revisions
Jump to navigation
Jump to search
imported>Howard C. Berkowitz No edit summary |
imported>Howard C. Berkowitz No edit summary |
||
Line 1: | Line 1: | ||
{{subpages}} | {{subpages}} | ||
{{TOC|right}} | |||
In [[medicine]], '''fatty liver''', also called '''hepatic steatosis''' or '''liver steatosis''' is "lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of [[triglyceride]]s, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of [[fatty acid]]s."<ref>{{MeSH}}</ref> | In [[medicine]], '''fatty liver''', also called '''hepatic steatosis''' or '''liver steatosis''' is "lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of [[triglyceride]]s, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of [[fatty acid]]s."<ref>{{MeSH}}</ref> | ||
Revision as of 09:12, 13 June 2010
In medicine, fatty liver, also called hepatic steatosis or liver steatosis is "lipid infiltration of the hepatic parenchymal cells resulting in a yellow-colored liver. The abnormal lipid accumulation is usually in the form of triglycerides, either as a single large droplet or multiple small droplets. Fatty liver is caused by an imbalance in the metabolism of fatty acids."[1]
Fatty liver includes steatohepatitis.
Etiology / cause
Fatty liver and steatohepatitis may be caused by the single-nucleotide polymorphisms rs2854116 (c.455T>C) and rs2854117 (c.482C>T) of apolipoprotein C-III which are also associated with insulin resistance and hypertriglyceridemia.[2]
Prognosis
Obesity may be the cause of cirrhosis in 12% of patients.[3][4]
References
- ↑ Anonymous (2024), Fatty liver (English). Medical Subject Headings. U.S. National Library of Medicine.
- ↑ Petersen KF, Dufour S, Hariri A, Nelson-Williams C, Foo JN, Zhang XM et al. (2010). "Apolipoprotein C3 gene variants in nonalcoholic fatty liver disease.". N Engl J Med 362 (12): 1082-9. DOI:10.1056/NEJMoa0907295. PMID 20335584. Research Blogging.
- ↑ Wanless IR, Lentz JS (1990). "Fatty liver hepatitis (steatohepatitis) and obesity: an autopsy study with analysis of risk factors.". Hepatology 12 (5): 1106-10. PMID 2227807.
- ↑ Sheth SG, Gordon FD, Chopra S (1997). "Nonalcoholic steatohepatitis.". Ann Intern Med 126 (2): 137-45. PMID 9005748.